stockrowAlkermes plc (ALKS) vs Liquidia Corporation (LQDA)
- Alkermes plc ALKS 44.61 −2.79%
- Liquidia Corporation LQDA 44.69 −5.68%
Alkermes plc and Liquidia Corporation are both Drug Manufacturers Specialty & Generic companies. Alkermes plc is the larger, with a market value of $7.5B against $4.0B — 1.9× the size. Alkermes plc has negative trailing earnings, so its P/E is not meaningful; Liquidia Corporation trades at 28.5×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against 15.3%. Liquidia Corporation has the higher net margin (30.7% vs −0.02%) and the higher return on invested capital (121.1% vs 1.54%). Across the 20 metrics below, Liquidia Corporation leads on 14 and Alkermes plc on 6.
Valuation
Profitability
| Metric | ALKS | LQDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 82.89% | 92.54% | 53.51% |
| Operating margin | 3.66% | 37.39% | 0.00% |
| Net margin | (0.02%) | 30.74% | (2.45%) |
| Free cash flow margin | 13.03% | 33.42% | 0.00% |
| Return on equity | (0.02%) | 131.82% | (0.80%) |
| Return on assets | (0.01%) | 35.57% | (1.67%) |
| Return on invested capital | 1.54% | 121.05% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack